<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HF736405BFB9941A4988DA76B00B8A0FF" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2433 IH: 21st Century Cures Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2433</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150519">May 19, 2015</action-date> 
<action-desc><sponsor name-id="B001257">Mr. Bilirakis</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.</official-title> 
</form> 
<legis-body id="H1993C046F1354F83AE99D9A8E016166B" style="OLC"> 
<section id="H06CD057EEF1245ABB8B0AD62CC32672E" section-type="section-one"><enum>1.</enum><header>Enhancing combination products review</header><text display-inline="no-display-inline">Section 503(g)(4)(C) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/353">21 U.S.C. 353(g)(4)(C)</external-xref>) is amended by adding at the end the following new clause: </text> <quoted-block style="traditional" id="H66392F15B15E405CAB0573943E204173" display-inline="no-display-inline"> <clause id="H146FFC2DC26347E685704F4CA10D8C52" indent="up2"><enum>(iii)</enum><text display-inline="yes-display-inline">Not later than 18 months after the date of the enactment of the <short-title>21st Century Cures Act</short-title>, the Secretary shall issue final guidance that describes the responsibilities of each agency center regarding its review of combination products. The Secretary shall, after soliciting public comment, review and update the guidance periodically.</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></section> 
</legis-body> 
</bill> 

